JO2236B1 - Carbamic acid derivatives - Google Patents

Carbamic acid derivatives

Info

Publication number
JO2236B1
JO2236B1 JO200049A JOP20000049A JO2236B1 JO 2236 B1 JO2236 B1 JO 2236B1 JO 200049 A JO200049 A JO 200049A JO P20000049 A JOP20000049 A JO P20000049A JO 2236 B1 JO2236 B1 JO 2236B1
Authority
JO
Jordan
Prior art keywords
lower alkyl
signifies
hydrogen
phenyl
caused
Prior art date
Application number
JO200049A
Other languages
Arabic (ar)
Inventor
ميوتل فينست
فييرا ايريك
ويكمان جيرغن
بليتشر كونراد
جوهانز ولترينغ ثوماس
Original Assignee
اف. هوفمان- لاروش أيه جي‏
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by اف. هوفمان- لاروش أيه جي‏ filed Critical اف. هوفمان- لاروش أيه جي‏
Priority to JO200049A priority Critical patent/JO2236B1/en
Application granted granted Critical
Publication of JO2236B1 publication Critical patent/JO2236B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to compounds of formula Wherein R1 signifies hydrogen or lower alkyl R2.R3 signify, independently from each other, hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl X signifies O,S or two hydrogen, atoms not forming a bridge A1/A2 signify, independently from each other, phenyl or a 6-membered heterocycle containing 1 or 2 nitrogen atoms B is a group of formula Wherein R3 signifies lower alkyl, lower alkenyl, lower alkinyl, benzyl, lower alkyl- cycloalkyl, lower alkyl- cyano, lower alkyl- pyridinyl, lower alkyl-lower, lower alkoxy-phenyl, lower alkyl-phenyl, which is optionally substituted by lower alkoxy, or phenyl, which is optionally substituted by lower alkoxy, or lower alkyl-thienyl, cycloalkyl, lower alkyl- trifluoromethyl, or lower alkyl – morpholinyl, Y signifies –O,S or a bond Z signifies O.or S Or B is a -5- membered heterocyclic group of formula Wherein R4 and R5 signifies hydrogen, lower alkyl, lower alkoxy, cyclohexyl, lower alkyl- cyclohexyl or trifluoromethyl, with the proviso that at least one of R4 or R5 has to be hydrogen as well as to their pharmaceutically acceptable salts These compounds may be used in the control or prevention of acute and or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia caused by pregnancy, cardiac arrest, hypoglycaemia, alheimer’s disease, huntington’s chorea, Als, dementia caused by AIDS , eye injuries, retinopathy, cognitive disorders, memory deficits, schizophrenia, idiopathic parkinsonism or parkinsonism caused by medicaments as well as conditions which lead to glutamate deficiency functions, such as e’g, muscle spasms, convulsions, migraine, urinary incontinence, nicotine addiction, psychoses, opiate addition, anxiety, vomiting , acute and chronic pain, dyskinesia and depression
JO200049A 2000-04-13 2000-04-13 Carbamic acid derivatives JO2236B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JO200049A JO2236B1 (en) 2000-04-13 2000-04-13 Carbamic acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JO200049A JO2236B1 (en) 2000-04-13 2000-04-13 Carbamic acid derivatives

Publications (1)

Publication Number Publication Date
JO2236B1 true JO2236B1 (en) 2004-10-07

Family

ID=48052137

Family Applications (1)

Application Number Title Priority Date Filing Date
JO200049A JO2236B1 (en) 2000-04-13 2000-04-13 Carbamic acid derivatives

Country Status (1)

Country Link
JO (1) JO2236B1 (en)

Similar Documents

Publication Publication Date Title
MY126586A (en) Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
CA2243234A1 (en) 5h-thiazolo[3,2-a]pyrimidine derivatives
RU2356903C2 (en) C-6 modified indazolyl pyrrolotriazines
RS20050195A (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
ATE122233T1 (en) METHOD FOR USING (2-IMIDAZOLINE-2-YLAMINO)-QUINOXALINES FOR LOWERING OR STABILIZING INTRAOCULAR PRESSURE.
WO2001029011A3 (en) Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
TW200505907A (en) Piperidine-benzenesulfonamide derivatives
PE20010759A1 (en) BENZODIAZEPINE DERIVATIVES AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEPTOR
EA200300718A1 (en) 3-INDOLINE DERIVATIVES THAT CAN BE APPLIED FOR THE TREATMENT OF PSYCHIATRIC AND NEUROLOGICAL DISORDERS
MXPA04000278A (en) Use of nk-1 receptor antagonists with pyridinic structure, for the treatment of brain, spinal or nerve injury.
PE20021072A1 (en) DERIVATIVES OF DIHYDRO-BENZO (b) (1,4) -DIAZEPIN-2-ONA AS ANTAGONISTS I OF mGLUR2
ATE501141T1 (en) CONDENSED BIZYCLIC SUBSTITUTED AMINE AS HISTAMINE 3 RECEPTOR LIGANDS
HRP20090143T3 (en) N-oxides as prodrugs of piperazine&piperidine derivatives
PE135299A1 (en) DERIVATIVES OF 1,3,8-TRIAZA-ESPIRO [4,5] DECAN-4-ONA
PE20010494A1 (en) SUBSTITUTE PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY
JO2307B1 (en) Pyrimidine derivatives
JO2236B1 (en) Carbamic acid derivatives
MXPA02011464A (en) 1,4 diazepan 2,5 dione derivatives and their use as nk 1 receptor antagonists.
CA2388470A1 (en) Use of carbonylamino derivatives against cns disorders
CA2437006A1 (en) Aminotriazolopyridine derivatives as adenosine receptor ligands
MXPA04005554A (en) Benzothiazoles.
EP0449195A3 (en) Aminobenzene compounds, their production and use
DK0630893T3 (en) N, N'-disubstituted amide derivative
PL1603877T3 (en) NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS
ECSP003444A (en) DERIVATIVES OF CARBAMIC ACID